FUSE-394

N/A

Report date: 2026/03/19 16:57:38

Base Information

Drug NameFUSE-394
Drug Alias Nameanti-ROR1/anti-CD3 bispecific T-cell engager (Fuse Biotherapeutics)FUSE-394
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionInactive tyrosine-protein kinase transmembrane receptor ROR1 modulatorsT cell surface glycoprotein CD3 modulators
TargetsT cell surface glycoprotein CD3Inactive tyrosine-protein kinase transmembrane receptor ROR1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFuse Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesFuse Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A